Low aspirin use in diabetics

Area of Science:

• Cardiology and Diabetes Mellitus Research
• Public Health and Preventive Medicine

Background:

• Cardiovascular disease (CVD) is a major complication in patients with diabetes mellitus.
• Aspirin is recommended for primary and secondary prevention of CVD in diabetic patients.
• Current aspirin utilization patterns in this population require investigation.

Purpose of the Study:

• To ascertain the prevalence of aspirin use in adult diabetics with established CVD or CVD risk factors.
• To examine demographic variations in aspirin use, specifically comparing males and females, and Saudi and non-Saudi populations.

Main Methods:

• Retrospective analysis of medical records from King Abdulaziz University Hospital (1998-2000).
• Data collected included patient demographics, diabetes status, CVD history, CVD risk factors (hypertension, hyperlipidemia, obesity, smoking, family history), and aspirin usage.
• Statistical analysis was performed to identify trends and significant differences.

Main Results:

• Out of 550 diabetic patients, aspirin use was significantly higher in those with CVD (63%) compared to those without (12%).
• Aspirin use was 29% in males versus 22% in females, and 24% in Saudis versus 27% in non-Saudis, with no statistically significant differences.
• Overall aspirin use was found to be low in the studied diabetic population with CVD or risk factors.

Conclusions:

• Aspirin use is suboptimal in diabetic patients with cardiovascular disease and/or risk factors.
• There are no significant demographic disparities in aspirin use based on sex or nationality.
• Increased physician emphasis on prescribing aspirin for primary and secondary CVD prevention in diabetics is warranted.